| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.0036 | 0.9 |